Page last updated: 2024-12-04

4-hydroxyphenylpyruvic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxyphenylpyruvic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-hydroxyphenylpyruvic acid : A 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID979
CHEMBL ID607712
CHEBI ID15999
SCHEMBL ID24157
MeSH IDM0056183

Synonyms (91)

Synonym
3-(4-hydroxyphenyl)-2-oxo-propanoic acid
AC-7498
brn 2691632
einecs 205-852-9
3-(4-hydroxyphenyl)-2-oxo-propionic acid
3-(4-hydroxy-phenyl)pyruvic acid
3-(4-hydroxyphenyl)-2-oxopropanoic acid
CHEBI:15999 ,
3-(4-hydroxyphenyl)pyruvic acid
4-hydroxyphenylpyruvic acid
(4-hydroxyphenyl)pyruvic acid
4-hydroxy alpha-oxobenzenepropanoic acid
nsc666757
nsc-666757
3-(4-hydroxyphenyl)-2-oxopropionic acid
nsc 100738
pyruvic acid, p-hydroxyphenyl-
3-(p-hydroxyphenyl)-2-oxopropionic acid
benzenepropanoic acid, 4-hydroxy-alpha-oxo- (9ci)
4-hydroxy-a-oxobenzenepropanoic acid
pyruvic acid, (p-hydroxyphenyl)- (8ci)
3-(p-hydroxyphenyl)pyruvic acid
nsc 666757
4-hydroxy-alpha-oxobenzenepropanoic acid
hppa
testacide
benzenepropanoic acid, 4-hydroxy-alpha-oxo-
nsc100738
nsc-100738
benzenepropanoic acid, 4-hydroxy-.alpha.-oxo-
3-(p-hydroxyphenyl)-2-oxopropanoic acid
(p-hydroxyphenyl)pyruvic acid
156-39-8
p-hydroxyphenylpyruvic acid
testacid
pyruvic acid, (p-hydroxyphenyl)-
wln: qvv1r dq
ENO ,
4-hydroxyphenylpyruvate
C01179
4-hydroxyphenylpyruvic acid, 98%
H-7200
87E988C4-F26C-4E03-9A40-1B0C0B36CA67
4- hydroxyphenylpyruvic acid
DB07718
BMSE000262
(p-hydroxyphenyl)-pyruvic acid
4-hydroxy-phenylpyruvate
CHEMBL607712
AKOS000136920
A809744
GEO-01551
0yp1694wnq ,
4-10-00-03630 (beilstein handbook reference)
unii-0yp1694wnq
FT-0618738
S2995
4-hppa
gtpl6629
SCHEMBL24157
4-hydroxy-.alpha.-oxobenzenepropanoic acid
3-(4-hydroxy phenyl)-2-oxo propanoic acid
3-(4-hydroxyphenyl)-2-oxopropanoic acid #
FD10465
DTXSID80166017
mfcd00002591
4-hydroxyphenylpyruvic acid, grade ii, 98-100%, crystalline
3-(4-hydroxyphenyl)-2-oxopropionate
(p-hydroxyphenyl)-pyruvate
4-hydroxy-alpha-oxobenzenepropanoate
4-hydroxy-a-oxobenzenepropanoate
3-(4-hydroxyphenyl)-2-oxo-propanoate
(p-hydroxyphenyl)pyruvate
p-hydroxyphenylpyruvic
3-(p-hydroxyphenyl)-2-oxopropionate
4hppa
HY-W010040
CS-W010756
4-?hydroxyphenylpyruvic acid
BBL104224
STL558218
Q2823224
p-hydroxyphenyl-brenztraubensa currencyure
STR05283
AMY4735
3-(4-hydroxyphenyl)-2-oxopropanoicacid
4-ydroxyphenylpyruvic acid
PD005526
benzenepropanoic acid, ?-hydroxy-?-oxo-
EN300-1855716
SY050624

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The introduction of free blood tyrosine as such test appears to allow the development of safe individual strategy for the usage of glucocorticoids."( [The safety problem and a physiological strategy for using glucocorticoid hormones].
Piruzian, LA; Rass, IT,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
2-oxo monocarboxylic acidAny monocarboxylic acid having a 2-oxo substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (28)

PathwayProteinsCompounds
Metabolism14961108
Amino acid and derivative metabolism250260
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism4485
Phenylalanine and tyrosine catabolism1131
Tyrosine Metabolism1657
Phenylalanine and Tyrosine Metabolism1121
Phenylketonuria1121
Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)1121
Tyrosinemia Type 3 (TYRO3)1121
Alkaptonuria1657
Hawkinsinuria1657
Tyrosinemia Type I1657
Disulfiram Action Pathway2366
Tyrosinemia, Transient, of the Newborn1657
Dopamine beta-Hydroxylase Deficiency1657
Monoamine Oxidase-A Deficiency (MAO-A)1657
Tyrosine Biosynthesis519
Plastoquinol-9 Biosynthesis616
Isoquinoline Alkaloid Biosynthesis513
Tyrosine metabolism ( Tyrosine metabolism )2841
2-Oxo-glutaric acid + L-Tyrosine = L-Glutamic acid + 4-Hydroxy-phenyl-pyruvic acid ( Tyrosine metabolism )14
Phenylalanine and tyrosine metabolism1132
Tyrosine catabolism515
Farnesyl to CoQ10 metabolism09
tyrosol biosynthesis06
ubiquinone (coenzyme Q) biosynthesis026
Biochemical pathways: part I0466
tyrosine degradation I212
Vitamin E biosynthesis514

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 20Mus musculus (house mouse)Ki66.03461.10006.67899.1201AID360149
Solute carrier family 22 member 6Mus musculus (house mouse)Ki72.86090.40745.02179.4000AID360150; AID598874; AID598880
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneKappa-type opioid receptorMus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID360149Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID598874Inhibition of mouse Oat1 expressed in Xenopus oocytes assessed as inhibition 6-carboxyfluorescein uptake after 1 hr by fluorometric analysis2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).
AID360150Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID360151Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID410824Activity of human recombinant MIF tautomerase by LB plot in presence of 3 uM ZINC002729792009Journal of medicinal chemistry, Jan-22, Volume: 52, Issue:2
Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.
AID410825Activity of human recombinant MIF tautomerase by LB plot in presence of 5 uM ZINC002729792009Journal of medicinal chemistry, Jan-22, Volume: 52, Issue:2
Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.
AID411002Activity of human recombinant MIF tautomerase by LB plot in presence of 5 uM ZINC008062722009Journal of medicinal chemistry, Jan-22, Volume: 52, Issue:2
Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.
AID411001Activity of human recombinant MIF tautomerase by LB plot in presence of 3 uM ZINC008062722009Journal of medicinal chemistry, Jan-22, Volume: 52, Issue:2
Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.
AID598880Inhibition of mouse Oat1 expressed in Xenopus oocytes2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (98)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (25.51)18.7374
1990's18 (18.37)18.2507
2000's25 (25.51)29.6817
2010's25 (25.51)24.3611
2020's5 (5.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.16 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index44.88 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.00%)6.00%
Case Studies6 (6.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]